SCHEMBL7741914

SCHEMBL7741914

CCOC(=O)c1c(O)c(=O)n(Cc2nc3ccccc3n2CCCCF)c2ccccc12

nearest known ligand 0.54

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
HTT P42858 3/20 0.53
LMNA P02545 4/20 0.52
KDM4E B2RXH2 3/20 0.52
L3MBTL1 Q9Y468 1/20 0.48
RECQL P46063 2/20 0.43
SMN1; SMN2 Q16637 5/20 0.41
USP2 O75604 1/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
POLB P06746 1/20 0.41
HPGD P15428 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
BLM P54132 1/20 0.41
CNR2 P34972 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7746367 0.89 ALDH1A1 (0.48) ALDH1A1HTTLMNAKDM4EL3MBTL1
SCHEMBL7746351 0.87 FEN1 (0.44) ALDH1A1HTTLMNAKDM4ERECQL
SCHEMBL7747488 0.76 SMN1; SMN2 (0.40) ALDH1A1HTTLMNAL3MBTL1RECQL
SCHEMBL14848270 0.76 KDM4E (0.66) ALDH1A1HTTLMNAKDM4EL3MBTL1
SCHEMBL7745656 0.75 TDP1 (0.45) ALDH1A1HTTLMNAKDM4EL3MBTL1
SCHEMBL7746911 0.74 MEN1 (0.45) ALDH1A1LMNAKDM4EL3MBTL1RECQL
SCHEMBL7745691 0.73 SMN1; SMN2 (0.47) ALDH1A1LMNAKDM4EL3MBTL1RECQL
SCHEMBL7746317 0.72 MEN1 (0.43) ALDH1A1HTTLMNAL3MBTL1RECQL
SCHEMBL14829909 0.72 ALDH1A1 (0.80) ALDH1A1HTTLMNAKDM4EL3MBTL1
SCHEMBL7746499 0.72 MEN1 (0.42) L3MBTL1RECQLSMN1; SMN2USP2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed
US-6774134-B2 FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION BRISTOL-MYERS SQUIBB COMPANY 2004-08-10 US disclosed